Your browser doesn't support javascript.
loading
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report.
Broudic-Guibert, Morgane; Blay, Jean-Yves; Vazquez, Léa; Evrard, Alexandre; Karanian, Marie; Taïeb, Sophie; Hoog-Labouret, Natalie; Oukhatar, Céline Mahier Ait; Boustany-Grenier, Rania; Arnaud, Antoine.
Afiliação
  • Broudic-Guibert M; Sainte-Catherine Institut, 250 Chemin de Baigne-Pieds, 84000, Avignon, France.
  • Blay JY; Léon Bérard Center, University Claude Bernard Lyon 1, Lyon, France.
  • Vazquez L; Sainte-Catherine Institut, 250 Chemin de Baigne-Pieds, 84000, Avignon, France.
  • Evrard A; University Hospital Center Carémeau, Nîmes, France.
  • Karanian M; Léon Bérard Center, University Claude Bernard Lyon 1, Lyon, France.
  • Taïeb S; Oscar Lambret Center, Lille, France.
  • Hoog-Labouret N; INCA, Boulogne Billancourt, France.
  • Oukhatar CMA; UNICANCER, Paris, France.
  • Boustany-Grenier R; Sainte-Catherine Institut, 250 Chemin de Baigne-Pieds, 84000, Avignon, France.
  • Arnaud A; Sainte-Catherine Institut, 250 Chemin de Baigne-Pieds, 84000, Avignon, France. a.arnaud@isc84.org.
J Med Case Rep ; 13(1): 245, 2019 Jul 25.
Article em En | MEDLINE | ID: mdl-31340860

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ameloblastoma / Inibidores de Proteínas Quinases / Vemurafenib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ameloblastoma / Inibidores de Proteínas Quinases / Vemurafenib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article